Please Wait
Applying Filters...
menu
    • menu
    FDA approvals drop 24% in H1 2025; GSK’s UTI med, Vertex’s non-opioid painkiller lead pack of first-in-class meds

    Data Compilation
    #PharmaFlow

    Pipeline Prospector August 2025: Novo’s Wegovy approved for MASH, Tonix Pharma’s fibromyalgia drug okayed

    Stock Recap
    #PipelineProspector

    Menu

    Arava, Leflunomide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,038Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to access your PharmaMiles and download the data

    Last Updated on PharmaCompass Virtual Booth Country Name of the Firm Written Confirmation No. Product Name Issue Date Valid Till Address of the Firm
    06/09/2025 Alembic Pharmaceuticals Limited
    India
    		 M/s. Alembic Pharmaceuticals Limited WC-0081 Leflunomide Ph. Eur. 08-08-2025 02-07-2028 API Division Panelav, At & Post. - Panelav, Tal. — Halol, Dist. - Panchmahal -389350, Gujarat, India
    04/06/2025 Cipla
    India
    		 M/s Cipla Limited WC-0113 Leflunomide BP 2022-06-20 2025-08-08 Old Madras Road, Virgo Nagar Post, Bengaluru - 560 049